Prague-based PPF Group has acquired a 19.2% stake in Autolus Therapeutics plc, a developer of T cell cancer therapies. ...
French biotech Inotrem SA raised €39m to finance Phase IIb efficacy testing of its TREM1 blocker nangibotide (Motrem) in...
Paris-based Ermium Therapeutics has completed a Series A financing to develop breakthrough auto-immune therapeutics.
German and US researchers have found a biomarker that identifies tumours responding to CTLA-4 checkpoint blockers.
SIGN UP FOR OUR FREE NEWSLETTER
BACKGROUND
Although it has only been shown to provide partial protection, the first-ever malaria vaccine is in testing in Africa...
SERVICE
VIDEO
Scientists from the University of Washington are using the Phenoglyphs machine learning module to achieve faster high-content analysis through automation and simplification.
ADVERTORIAL
BioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. Their proprietary EchoLUTION single-step technology avoids the use of...
THE MAG
NEXT ISSUE
CURRENT ISSUE
The Art of Biomarker Validation
Developing safe and effective medications is no easy task. Every year, the pharma industry loses hundreds of billions of dollars due to...
CURRENT SPECIAL
CURRENT ISSUE
CMOs & CROs
Hot topics in biomanufacturing, packaging & contract research. Get on board now!
SPECIALS
SEE ALL
PEOPLE
APPOINTMENTS
OPINION
Events
EVENT HIGHLIGHT
Exclusively designed for stakeholders within the diagnostics and research tool industry.
Always on the first day of MEDICA® in Dusseldorf!
UPCOMING EVENTS
European Biotech Week 2019
23.09.
- 29.09.2019
ǀ EU
ILMAC 2019
24.09.
- 27.09.2019
ǀ Basel (CH)
9th International Conference on Biotechnology and Bioengineering – ICBB
25.09.
- 28.09.2019
ǀ Poznan (PL)
EFIB 2019
30.09.
- 02.10.2019
ǀ Brussels (B)